Citation

64 FR 19543

Canonical document for this Federal Register citation.

Draft Guidance for Industry on IND's for Phase 2 and 3 Studies of Drugs, Including Specified Therapeutic Biotechnology-Derived Products; Chemistry, Manufacturing, and Controls Content and Format; Availability Wednesday, April 21, 1999 64 FR 19543